Staff Publications Received in the Month of January 2013

 Staff Publications Received in the Month of January 2013

 

1.         Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, Evens AM, Benjamin RS. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas(dagger). Annals of Oncology.24(1):257-63, Jan, 2013. Read the article

 

2.         Aird KM, Zhang R. Detection of Senescence-Associated Heterochromatin Foci (SAHF). Methods in molecular biology (Clifton, NJ).965:185-96, 2013 PMCID: PMC3552318. Read the article

 

3.          Hui, SKA, Nazir N, Faseru B, Ellerbeck EF. Ongoing self-engagement in quit attempts and cessation outcomes among rural smokers who were unable to quit after 2 years of repeated interventions. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.29(1):106-12, Jan, 2013 PMCID: PMC3539219. Read the article

 

4.         Behrend SW. Oncology update. Oncol Nurs Forum.40(1):95-6, Jan 1, 2013 Read the article

 

5.         Belinsky MG, Rink L, Flieder DB, Jahromi MS, Schiffman JD, Godwin AK, von Mehren M. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors. Genes Chromosomes & Cancer.52(2):214-24, Feb, 2013 PMCID: NIHMS 430867. Read the article

 

6.         Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative Delays in the US Medicare Population With Breast Cancer. J Clin Oncol.30(36):4485-92, Dec 20, 2012 PMCID: PMC 3518727. Read the article

 

7.         Bleicher RJ, Sigurdson ER. Breast cancer. Conclusions. Current problems in cancer.36(5):325, Sep-Oct, 2012 PMCID: Editorial. Read the article

 

8.         Bleicher RJ, Sigurdson ER. Breast cancer. Introduction. Current problems in cancer.36(5):232-3, Sep-Oct, 2012 PMCID: Editorial. Read the article

 

9.         Bradbury AR, Patrick-Miller L, Egleston BL, Schwartz LA, Sands CB, Shorter R, Moore CW, Tuchman L, Rauch P, Malhotra S, Rowan B, Van Decker S, Schmidheiser H, Bealin L, Sicilia P, Daly MB. Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Research and Treatment.136(3):749-57, Dec, 2012 PMCID: PMC 3513641. Read the article

 

10.       Chun YS, Zimmitti G. Fibrolamellar variant of hepatocellular carcinoma. Recent Results Cancer Res.190:101-10, 2013. [Review]

 

11.       Cole M, Padmanabhan A. Breast Cancer Treatment of Women with Schizophrenia and Bipolar Disorder from Philadelphia, PA: Lessons Learned and Suggestions for Improvement. Journal of Cancer Education.27(4):774-9, Sep, 2012. Read the article

 

12.       Dong X, Alpaugh KR, Cristofanilli M. Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis. Chin J Cancer Res.24(4):388-98, Dec, 2012. Read the article

 

13.       Doss M. Evidence supporting radiation hormesis in atomic bomb survivor cancer mortality data. Dose-response : a publication of International Hormesis Society.10(4):584-92, Dec, 2012 PMCID: PMC3526329. Read the article

 

14.       Doss M. Shifting the paradigm in radiation safety. Dose-response : a publication of International Hormesis Society.10(4):562-83, Dec, 2012 PMCID: PMC3526328. Read the article

 

15.       Giordano A, Gao H, Anfossi S, Cohen E, Mego M, Lee BN, Tin S, De Laurentiis M, Parker CA, Alvarez RH, Valero V, Ueno NT, De Placido S, Mani SA, Esteva FJ, Cristofanilli M, Reuben JM. Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer. Molecular Cancer Therapeutics.11(11):2526-34, Nov, 2012 PMCID: PMC 3500676. Read the article

 

16.       Golovine KV, Makhov PB, Teper E, Kutikov A, Canter D, Uzzo RG, Kolenko VM. Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. Prostate.73(1):23-30, Jan, 2013 PMCID: PMC 3491117. Read the article

 

17.       Gorin A, Gabitova L, Astsaturov I. Regulation of cholesterol biosynthesis and cancer signaling. Current Opinion in Pharmacology.12(6):710-6, Dec, 2012 PMCID: PMC 3504641.

 

18.       Hall MJ, Manne SL, Myers RE, Keenan EM, Balshem AM, Weinberg DS. Predictors of patient uptake of colorectal cancer gene environment risk assessment. Genome Med.4(11):92, Nov 29, 2012. Read the article

 

19.       Husain H, Psyrri A, Markovic A, Rampias T, Pectasides E, Wang H, Slebos R, Yarbrough WG, Burtness B, Chung CH. Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma. Laryngoscope.122(12):2762-8, Dec, 2012. Read the abstract

 

20.       Johnson ME, Buyyounouski MK. Androgen deprivation therapy toxicity and management for men receiving radiation therapy. Prostate cancer.2012:580306, 2012 PMCID: PMC3544287. Read the article

 

21.       Li H, Cai Q, Wu H, Vathipadiekal V, Dobbin ZC, Li TY, Hua X, Landen CN, Birrer MJ, Sanchez-Beato M, Zhang RG. SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK. Molecular Cancer Research.10(11):1462-72, Nov, 2012 PMCID: PMC 3501543. Read the article

 

22.       Li L, Li T, Cohen RJ, Anderson PR, Goldstein LJ, Bleicher RJ, Freedman GM. Identifying patients who may be candidates for a clinical trial of salvage accelerated partial breast irradiation after previous whole breast irradiation. International journal of breast cancer.2012:937658, 2012 PMCID: PMC3518959.Read the article

 

23.       Malofeeva EV, Domanitskaya N, Gudima M, Hopper-Borge EA. Modulation of the ATPase and Transport Activities of Broad-Acting Multidrug Resistance Factor ABCC10 (MRP7). Cancer Research.72(24):6457-67, Dec, 2012 PMCID: PMC 3525726. Read the article

 

24.       Patel BB, Barrero CA, Braverman A, Kim PD, Jones KA, Chen DE, Bowler RP, Merali S, Kelsen SG, Yeung AT. Assessment of Two Immunodepletion Methods: Off-Target Effects and Variations in Immunodepletion Efficiency May Confound Plasma Proteomics. Journal of Proteome Research.11(12):5947-58, Dec, 2012 PMCID: PMC 3518753. Read the article

 

25.       Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomaki K, Amiano P, Apicella C, Baglietto L, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Brauch H, Brinton L, Bui QM, Buring JE, Buys SS, Campa D, Carpenter JE, Chasman DI, Chang-Claude J, Chen C, Clavel-Chapelon F, Cox A, Cross SS, Czene K, Deming SL, Diasio RB, Diver WR, Dunning AM, Durcan L, Ekici AB, Fasching PA, Feigelson HS, Fejerman L, Figueroa JD, Fletcher O, Flesch-Janys D, Gaudet MM, Gerty SM, Rodriguez-Gil JL, Giles GG, van Gils CH, Godwin AK, Graham N, Greco D, Hall P, Hankinson SE, Hartmann A, Hein R, Heinz J, Hoover RN, Hopper JL, Hu JJ, Huntsman S, Ingles SA, Irwanto A, Isaacs C, Jacobs KB, John EM, Justenhoven C, Kaaks R, Kolonel LN, Coetzee GA, Lathrop M, Marchand L, Lee AM, Lee IM, Lesnick T, Lichtner P, Liu JJ, Lund E, Makalic E, Martin NG, McLean CA, Meijers-Heijboer H, Meindl A, Miron P, Monroe KR, Montgomery GW, Muller-Myhsok B, Nickels S, Nyante SJ, Olswold C, Overvad K, Palli D, Park DJ, Palmer JR, Pathak H, Peto J, Pharoah P, Rahman N, Rivadeneira F, Schmidt DF, Schmutzler RK, Slager S, Southey MC, Stevens KN, Sinn HP, Press MF, Ross E, Riboli E, Ridker PM, Schumacher FR, Severi G, Silva ID, Stone J, Sund M, Tapper WJ, Thun MJ, Travis RC, Turnbull C, Uitterlinden AG, Waisfisz Q, Wang XS, Wang ZM, Weaver J, Schulz-Wendtland R, Wilkens LR, Van Den Berg D, Zheng W, Ziegler RG, Ziv E, Nevanlinna H, Easton DF, Hunter DJ, Henderson BE, Chanock SJ, Garcia-Closas M, Kraft P, Haiman CA, Vachon CM. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Human Molecular Genetics.21(24):5373-84, Dec, 2012 PMCID: PMC 3510753. Read the article

 

26.       Simhan J, Canter DJ, Sterious SN, Smaldone MC, Tsai KJ, Li TY, Viterbo R, Chen DYT, Greenberg RE, Kutikov A, Uzzo RG. Pathological Concordance and Surgical Outcomes of Sporadic Synchronous Unilateral Multifocal Renal Masses Treated with Partial Nephrectomy. Journal of Urology.189(1):43-7, Jan, 2013. Read the article

 

27.       Tang PA, Cohen SJ, Kollmannsberger C, Bjarnason G, Virik K, MacKenzie MJ, Lourenco L, Wang L, Chen A, Moore MJ. Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer. Clinical Cancer Research.18(21):6023-31, Nov, 2012. Read the article

 

28.       Teper E, Makhov P, Golovine K, Canter DJ, Myers CB, Kutikov A, Sterious SN, Uzzo RG, Kolenko VM. The Effect of 5-Aminolevulinic Acid and Its Derivatives on Protoporphyrin IX Accumulation and Apoptotic Cell Death in Castrate-resistant Prostate Cancer Cells. Urology.80(6):1391.e1-.e7, 2012 PMCID: PMC 3514607. Read the article

 

29.       Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH. Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Research and Treatment.136(3):813-21, Dec, 2012 PMCID: PMC 3513497. Read the article

 

30.       Weinfurt KP, Seils DM, Lin L, Sulmasy DP, Astrow AB, Hurwitz HI, Cohen RB, Meropol NJ. Research Participants’ High Expectations of Benefit in Early-Phase Oncology Trials: Are We Asking the Right Question? Journal of Clinical Oncology.30(35):4396-400, Dec, 2012. Read the article

 

31.       Weiss RF, Miller MG, Cronin JF, Hensley HH, Joshi ID, Smith MR. Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma. Plos One.7(12), Dec, 2012 PMCID: PMC 3522695. Read the article

 

32.       Zelenetz AD, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad L, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Pro B, Reddy N, Sokol L, Swinnen L, Tsien C, Vose JM, Yahalom J, Zafar N, Naganuma M, Dwyer MA. Non-Hodgkin’s Lymphomas, Version 3.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network.10(12):1487-98, Dec, 2012. Read the article

 

 

FW: New! Access to enhanced site license to Annals of Internal Medicine

I am pleased to announce that the Fox Chase community now has access to additional resources through our site license with Annals of Internal Medicine published by the American College of Physicians.  As always, you can access the journal from the library’s Journal Holdings or type in www.annals.org.

Here are some of the new features:

Remote access from home or during travel

• ACP Journal Club is a monthly feature of Annals that includes the best new evidence for internal medicine from more than 130 journals.
• In the Clinic offers evidence-based answers to frequently asked questions about screening, prevention, diagnosis, therapy, and patient education and provides clinicians with tools to improve the quality of care.  More than 90 topics now covered.
• Online First presents articles released ahead of print.
• Downloadable Teaching Tools provide content in formats ideal for teaching.
• Medical Humanities are included with hundreds of articles from the famed “On Being a Doctor” Series and Ad Libitum.
• Specialty collections offer discipline-specific content that gives you quick access to all articles in a topic area.  Some of these include hospital medicine, end of life care, hematology/ oncology and more.
• Multimedia is available in issue-summary podcasts, author-insight videos, and much more!

Happy reading!

-Beth

Staff Pubs rec’d in December 2012

As always, these citations are archived in the Staff Publications database accessible from the Talbot Research Library.  NIH is getting serious about open access compliance; please contact me with your questions and for assistance.

 Staff Publications Received in the Month of December 2012

Adelstein DJ, Ridge JA, Brizel DM, Holsinger FC, Haughey BH, O’Sullivan B, Genden EM, Beitler JJ, Weinstein GS, Quon H, Chepeha DB, Ferris RL, Weber RS, Movsas B, Waldron J, Lowe V, Ramsey S, Manola J, Yueh B, Carey TE, Bekelman JE, Konski AA, Moore E, Forastiere A, Schuller DE, Lynn J, Ullmann CD. Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck.34(12):1681-703, Dec, 2012. Read the article

2.         Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecologic Oncology.127(3):451-5, Dec, 2012. Read the article

3.         Asge Technology Committee, Banerjee S, Barth BA, Bhat YM, Desilets DJ, Gottlieb KT, Maple JT, Pfau PR, Pleskow DK, Siddiqui UD, Tokar JL, Wang A, Song LM, Rodriguez SA. Endoscopic closure devices. Gastrointest Endosc.76(2):244-51, Aug, 2012.  [Review] Read the article

4.         Asge Technology Committee, Barth BA, Banerjee S, Bhat YM, Desilets DJ, Gottlieb KT, Maple JT, Pfau PR, Pleskow DK, Siddiqui UD, Tokar JL, Wang A, Song LM, Rodriguez SA. Equipment for pediatric endoscopy. Gastrointest Endosc.76(1):8-17, Jul, 2012. [Review] Read the article

5.         Asge Technology Committee, Kethu SR, Banerjee S, Barth BA, Desilets DJ, Kaul V, Pedrosa MC, Pfau PR, Pleskow DK, Tokar JL, Wang A, Song LM, Rodriguez SA. Endoluminal bariatric techniques. Gastrointest Endosc.76(1):1-7, Jul, 2012. [Review] Read the article

6.         Asge Technology Committee, Wang A, Pleskow DK, Banerjee S, Barth BA, Bhat YM, Desilets DJ, Gottlieb KT, Maple JT, Pfau PR, Siddiqui UD, Tokar JL, Song LM, Rodriguez SA. Esophageal function testing. Gastrointest Endosc.76(2):231-43, Aug, 2012. [Review] Read the article

7.         Baden LR, Bensinger W, Angarone M, Casper C, Dubberke ER, Freifeld AG, Garzon R, Greene JN, Greer JP, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marr KA, Montoya JG, Morris-Engemann A, Pappas PG, Rolston K, Segal B, Seo SK, Swaminathan S, Naganuma M, Shead DA. Prevention and Treatment of Cancer-Related Infections. Journal of the National Comprehensive Cancer Network.10(11):1412-45, Nov, 2012. Read the article

8.         Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen XW, Bove B, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P. Identification of fifteen novel germline variants in the BRCA1 3 ‘ UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Human Mutation.33(12):1665-75, Dec, 2012. Read the article

9.         Burtness B, Marur S, Bauman JE, Golemis EA, Mehra R, Cohen SJ. Comment on “epidermal growth factor receptor is essential for toll-like receptor 3 signaling”. Sci Signal.5(254):lc5, 2012: Comment. Read the text

10.       Chen KT, Olszanski A, Farma JM. Donor transmission of melanoma following renal transplant. Case Rep Transplant.2012:764019, 2012 PMCID: PMC3504199. Read the article

11.       Chow HY, Jubb AM, Koch JN, Jaffer ZM, Stepanova D, Campbell DA, Duron SG, O’Farrell M, Cai KQ, Klein-Szanto AJP, Gutkind JS, Hoeflich KP, Chernoff J. p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model. Cancer Research.72(22):5966-75, Nov, 2012. PMCID: PMC3500416 Read the article

12.       Coleman RL, Sill MW, Lankes HA, Fader AN, Finkler NJ, Hoffman JS, Rose PG, Sutton GP, Drescher CW, McMeekin DS, Hu W, Deavers M, Godwin AK, Alpaugh RK, Sood AK. A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study. Gynecologic Oncology.127(3):538-43, Dec, 2012. PMCID:  NIHMS403184 Read the article

13.       Freedman GM, Anderson PR, Bleicher RJ, Litwin S, Li TY, Swaby RF, Ma CMC, Li JS, Sigurdson ER, Watkins-Bruner D, Morrow M, Goldstein LJ. Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer. International Journal of Radiation Oncology Biology Physics.84(4):888-93, Nov, 2012. PMCID: PMC3419789 Read the article

14.       Fury MG, Sherman E, Lisa D, Agarwal N, Algazy K, Brockstein B, Langer C, Lim D, Mehra R, Rajan SK, Korte S, Lipson B, Yunus F, Tanvetyanon T, Smith-Marrone S, Ng K, Xiao H, Hague S, Pfister DG. A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m(2) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer. Journal of the National Comprehensive Cancer Network.10(11):1391-8, Nov, 2012. Read the article

15.       Held-Warmkessel J. Penile cancer. Semin Oncol Nurs.28(3):190-201, Aug, 2012.  [Review] Read the article

16.       Jiang Z, Zhou Y, Devarajan K, Slater CM, Daly MB, Chen X. Identifying putative breast cancer-associated long intergenic non-coding RNA loci by high density SNP array analysis. Front Genet.3:299, 2012. PMCID: PMC3528021 Read the article

17.       Keller LMM, Sopka DM, Li TY, Klayton T, Li JS, Anderson PR, Bleicher RJ, Sigurdson ER, Freedman GM. Five-year Results of Whole Breast Intensity Modulated Radiation Therapy for the Treatment of Early Stage Breast Cancer: The Fox Chase Cancer Center Experience. International Journal of Radiation Oncology Biology Physics.84(4):881-7, Nov, 2012. Read the article

18.       Kim HJ, Barsevick AM, Fang CY, Miaskowski C. Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer Patients. Cancer Nursing.35(6):E1-E20, Nov-Dec, 2012. [Review] Read the article

19.       Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram. Prostate Cancer and Prostatic Diseases.15(4):374-9, Dec, 2012. Read the abstract

20.       Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, Uzzo RG. Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model. Journal of Urology.188(6):2077-83, Dec, 2012. Read the article

21.       Menges CW, Sementino E, Talarchek J, Xu JF, Chernoff J, Peterson JR, Testa JR. Group I p21-Activated Kinases (PAKs) Promote Tumor Cell Proliferation and Survival through the AKT1 and Raf-MAPK Pathways. Molecular Cancer Research.10(9):1178-88, Sep, 2012. PMCID: PMC3447107 Read the article

22.       Moore KN, Sill MW, Miller DS, McCourt C, De Geest K, Rose PG, Cardenes HR, Mannel RS, Farley JH, Schilder RJ, Fracasso PM. A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study. Gynecologic Oncology.127(3):456-61, Dec, 2012. Read the article

23.       Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray H, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O’Malley DM, Penson RT, Remmenga SW, Sabbatini P, Santoso JT, Schilder RJ, Schink J, Teng N, Werner TL, Hughes M, Dwyer MA. Ovarian Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network.10(11):1339-49, Nov, 2012. Read the article

24.       Pickard A, Cichon AC, Menges C, Patel D, McCance DJ. Regulation of Epithelial Differentiation and Proliferation by the Stroma: A Role for the Retinoblastoma Protein. Journal of Investigative Dermatology.132(12):2691-9, Dec, 2012. PMCID: PMC3443514 Read the article

25.       Plotnikova OV, Nikonova AS, Loskutov YV, Kozyulina PY, Pugacheva EN, Golemis EA. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis. Mol Biol Cell.23(14):2658-70, Jul, 2012 PMCID: PMC3395655. Read the article

26.       Rao SY, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu ZG, Jeffers JR, Rhodes M, Anderson S, Oravecz T, Hunger SP, Timakhov RA, Zhang RG, Balachandran S, Zambetti GP, Testa JR, Look AT, Wiest DL. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood.120(18):3764-73, Nov, 2012. PMCID: PMC3488889 Read the article

27.       Roscoe F, Xu RH, Sigal LJ. Characterization of Ectromelia Virus Deficient in EVM036, the Homolog of Vaccinia virus F13L, and Its Application for Rapid Generation of Recombinant Viruses. Journal of Virology.86(24):13501-7, Dec, 2012. PMCID: PMC3503138 Read the article

28.       Seeger-Nukpezah T, Golemis EA. The extracellular matrix and ciliary signaling. Current Opinion in Cell Biology.24(5):652-61, Oct, 2012. PMCID: PMC3479303 Read the article

29.       Shaheen NJ, Weinberg DS, Denberg TD, Chou R, Qaseem A, Shekelle P. Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Annals of Internal Medicine.157(11), Dec, 2012. Read the article

30.       Smaldone MC, Chen DY, Yu JQ, Plimack ER. Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer. Biologics.6:395-407, 2012. PMCID: PMC3508606 Read the article

31.       Smaldone MC, Egleston B, Uzzo RG, Kutikov A. Does Partial Nephrectomy Result in a Durable Overall Survival Benefit in the Medicare Population? Journal of Urology.188(6):2089-94, Dec, 2012. Read the article

32.       Stehman FB, Brady MF, Thigpen JT, Rossi EC, Burger RA. Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group Study. Gynecologic Oncology.127(3):495-501, Dec, 2012. Read the article

33.       Sterious S, Smaldone MC, Plimack E, Uzzo RG, Canter D, Kutikov A. Prolonged natural progression from localized to symptomatic renal cell carcinoma. Can J Urol.19(6):6578-80, Dec, 2012. Read the abstract

34.       Tannir NM, Plimack E, Ng C, Tamboli P, Bekele NB, Xiao LC, Smith L, Lim Z, Pagliaro L, Araujo J, Aparicio A, Matin S, Wood CG, Jonasch E. A Phase 2 Trial of Sunitinib in Patients with Advanced Non-clear Cell Renal Cell Carcinoma. European Urology.62(6):1013-9, Dec, 2012. Read the article

35.       Thompson HS, Sussner K, Schwartz MD, Edwards T, Forman A, Jandorf L, Brown K, Bovbjerg DH, Valdimarsdottir HB. Receipt of Genetic Counseling Recommendations Among Black Women at High Risk for BRCA Mutations. Genetic Testing and Molecular Biomarkers.16(11):1257-62, Nov, 2012. Read the article

36.       Thunnissen E, Beasley MB, Borczuk AC, Brambilla E, Chirieac LR, Dacic S, Flieder D, Gazdar A, Geisinger K, Hasleton P, Ishikawa Y, Kerr KM, Lantejoul S, Matsuno Y, Minami Y, Moreira AL, Motoi N, Nicholson AG, Noguchi M, Nonaka D, Pelosi G, Petersen I, Rekhtman N, Roggli V, Travis WD, Tsao MS, Wistuba I, Xu HD, Yatabe Y, Zakowski M, Witte B, Kuik DJ. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Modern Pathology.25(12):1574-83, Dec, 2012. Read the article

37.       Urban N, Thorpe J, Karlan BY, McIntosh MW, Palomares MR, Daly MB, Paley P, Drescher CW. Interpretation of Single and Serial Measures of HE4 and CA125 in Asymptomatic Women at High Risk for Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention.21(11):2087-94, Nov, 2012. PMCID: PMC3493821 Read the article

38.       Vadakara J, Borghaei H. Personalized medicine and treatment approaches in non-small-cell lung carcinoma. Pharmgenomics Pers Med.5:113-23, 2012. read the article

39.       Vadakara J, Pro B. Targeting CD30 in Anaplastic Large Cell Lymphoma. Current Hematologic Malignancy Reports.7(4):285-91, Dec, 2012. Read the article

40.       Van der Veken P, Fulop V, Rea D, Gerard M, Van Elzen R, Joossens J, Cheng JD, Baekelandt V, De Meester I, Lambeir AM, Augustyns K. P2-Substituted N-Acylprolylpyrrolidine Inhibitors of Prolyl Oligopeptidase: Biochemical Evaluation, Binding Mode Determination, and Assessment in a Cellular Model of Synucleinopathy. Journal of Medicinal Chemistry.55(22):9856-67, Nov, 2012. Read the article

41.       Xu QY, Chen Y, Grimm J, Fan JJ, An LL, Xue JY, Pahlajani N, LaCouture T. Dosimetric investigation of accelerated partial breast irradiation (APBI) using CyberKnife. Medical Physics.39(11):6621-8, Nov, 2012. Read the abstract

Best Wishes to all for a happy, healthy, and productive New Year!!

-Beth

Talbot Topics – Late December 2012

Subscription Changes

I am pleased to be able to offer access to the Fox Chase Cancer Center community to new titles of interest starting in 2013.  Here is a list of subscriptions new to the Talbot Research Library collection:

• Science Express (AAAS) – access pre-publication articles before they are added to Science
• Science Translational Medicine (AAAS)
• Cell Host & Microbe (Cell Press Elsevier)
• JoVE (Journal of Visualized Experiments) – General, Neuroscience, and Clinical & Translational Medicine sections
• Modern Pathology (NPG)
• JONA’s Healthcare Law, Ethics, & Regulation (LWW) (added July, 2012)
• Sleep Medicine Reviews (coming to our MD Consult package)
• Psych Journal (new opt-in title from Wiley)
• Clinical Liver Disease (new opt-in title from Wiley)
• Wiley Interdisciplinary Reviews: Membrane (new opt-in title from Wiley)

 Cancellations:

• Biotechniques (Print)
• Proceedings of the Annual Meeting of the AACR (print)
• Analytical Chemistry
• Health Psychology
• Journal of Pastoral Care & Counseling
• Inflammatory Bowel Diseases
• Science News (print & online)
• Journal of Nursing Care Quality (cancelled July, 2012)
• Nursing Made Incredibly Easy (cancelled July, 2012)
• SciFinder
• Neurology (leaving MD Consult package)
• Research Synthesis Methods (leaving Wiley opt-in)
• Thoracic Cancer (leaving Wiley opt-in)
• Wiley Interdisciplinary Reviews: Data Mining & Knowledge Discovery (leaving Wiley opt-in)
• Wiley Interdisciplinary Reviews: RNA ((leaving Wiley opt-in)

The Talbot Research Library’s Journals Holdings and database links are being updated to reflect these changes.

*******************************************************************

Journal Name Changes – JAMA Archives

The specialty Archives journals will change their names effective January 1, 2013.  We are working to make this transition as smoothly as possible; here’s a list of the old and new names:

Current Name	New Name
Archives of Dermatology	JAMA Dermatology · Archives of Internal Medicine JAMA Internal Medicine
Archives of Neurology	JAMA Neurology
Archives of Otolaryngology – Head & Neck Surgery	JAMA Otolaryngology  Head & Neck Surgery
Archives of General Psychiatry	JAMA Psychiatry
Archives of Surgery	JAMA Surgery

************************************************************************

From the Fox Chase Cancer Center Archives: Christmas Party Punch 

Do you remember the party punch that was mixed and served by senior leadership?  Here’s the genuine recipe for you to use at your own holiday celebration:

Fox Chase Punch

• 3 bottles white wine Chablis
• 2 bottles soda water
• 2 cups peach brandy
• 2 cups Benedictine
• Lemon juice (to taste)
• Raspberries or strawberries for garnish

Wishing you all a happy and healthy New Year!

New at FCCC – JoVE!

Dear FCCC Community:

I am delighted to inform you that Fox Chase Cancer Center now subscribes to JoVE, the world’s first peer-reviewed video journal for the sciences. JoVE’s mission is to increase productivity in scientific research and education — and we believe you will find their content a valuable addition to our current research resources.

What’s JoVE?

JoVE consists of videos of experimental procedures and protocols accompanied by textual descriptions.  Each article is constructed around a 5 to 10 minute professionally –produced video to allow researchers to re-create the technique described. The videos are divided into one to two minute chapters to make it easy to navigate.  Each chapter also includes written abstract, step-by-step directions, sample results and discussion, a detailed list of suppliers, and a reference list.

Access 

Talbot Research Library has subscribed to 3 out of 6 sections; JoVE General, JoVE Neuroscience, and JoVE Clinical and Translational Medicine. To access JoVE, click on the links listed on the library’s Journal Holdings page, or simply visit http://www.jove.com/” href=”http://www.jove.com/” target=”_blank”>http://www.jove.com from any computer.  You can also link to JoVE from PubMed, Google, or Google Scholar.

Videos must be watched on the JoVE website and cannot be downloaded.  The written materials can be downloaded into PDF files and can be exported into EndNote.

Content 

JoVE General (http://www.jove.com/general” href=”http://www.jove.com/general”>http://www.jove.com/general), JoVE Neuroscience (http://www.jove.com/neuro” href=”http://www.jove.com/neuro”>http://www.jove.com/neuro) and JoVE Clinical and Translational Medicine (http://www.jove.com/medicine” href=”http://www.jove.com/medicine”>http://www.jove.com/medicine) contain a broad range of techniques, protocols and procedures.  Areas covered include, but are not limited to:

Developmental biology
Molecular biology
Bioinformatics
Brain imaging
Neurobiology
Surgical subspecialties
Animal models of diseases

There are many features to the JoVE website and many ways that the articles can support your work. Please join us at tea tomorrow (Tuesday, December 11) where we will be doing demos and giving out giveaways to promote JoVe

Happy Reading – and Viewing!

—Beth

New Subscriptions!

Subject: NEW subscriptions!

Dear Fox Chase Community,

I am pleased to announce that Fox Chase now has online access to Science Express and Science Translational Medicine.  You can access them from the library’s Journals Holdings page or click on http://www.sciencemag.org/ and use the pull-down menu.

Science Express provides access to pre-publication articles and requires a separate subscription (I had received requests for it for several years).  Each week five to seven papers are selected and posted to the site.  Research articles are published within two weeks of acceptance, so now you are able to read the most pertinent research faster (four to six weeks faster than they appear in Science).

Science Translational Medicine’s goal is to improve the multidirectional process where basic research informs clinical research and vice versa.  Begun in 2009, this is the latest journal from the AAAS.  It is indexed in both pubmed and web of science, and has already received an impact factor of 7.804 in 2011.  It ranks 26 out of 181 in cell biology journals and 8 out of 112 in experimental research and medicine journals.  The content includes:

• Original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients’ lives (three to five research articles per week)

• Research and commentary on models of human disease with significant implications for disease treatment

• Investigative studies of human biology with an emphasis on disease, including small clinical trials

• Perspectives and reviews on research topics that discuss the implications of the findings from a basic science and clinical point of view

• Surveys of recent significant translational research findings from other publications

• Commentary on policy, funding, and regulatory issues

• Plus special issues featuring comprehensive reviews and in-depth analyses of current topics and an online multimedia center including Podcasts and Videos.

Here’s a link to a video with more info about Science Translational Medicine :

http://www.sciencemag.org/site/help/librarians/tutorial/stm_en/index.html

Happy Reading!

—Beth

New from the NIH regarding NIH Open Access Policy – Pls read

The NIH is getting serious about open access …

 

Last month the NIH issued a notice that they will “delay processing of non-competing continuation awards if publications arising from that award are not in compliance with the NIH public access policy”.  This will start in Spring 2013, so there is time to achieve compliance before consequences become enforced.

 

The NIH public access policy was enacted in 2008 requiring final peer-reviewed manuscripts of articles resulting from research funded by NIH to be deposited in the NIH digital archive, PubMed Central (PMC), upon acceptance for publication. The policy also requires that these papers are accessible to the public on PubMed Central no later than 12 months after publication. While there are many journals and many publishers who will facilitate depositing the articles, it is the responsibility of the author to make sure the articles are contained within PubMed Central (NIH’s repository).  Compliance is demonstrated by listing a PMCID number for each publication.

 

The Talbot Research Library is available to assist you in making your publications compliant.  If you are unfamiliar with the policy, please review the materials that we have posted on our webpage http://libguides.fccc.edu/nihpublicaccess and feel free to contact me with any questions that you may have.  If your are looking for PMCID numbers, please check the Staff Publications database first, as we have been adding PMCID numbers as we find them.  We are also happy to assist in depositing manuscripts into the NIH system; we will need for you to supply the final manuscript and the grant number(s) to do so.

Here are more tips to help you achieve and remain compliant:

• Acknowledge all NIH grants and CCSG-supported facilities in your manuscript.
• Act on reminder emails from library staff.
• Follow up with publishers whose journals deposit on your behalf.
• Set up a My NCBI account to sync with your ERA commons account (the “Awards” view  allows  you to view your compliance at a glance).
• Act on emails sent by the NIH to approve your manuscript.
• Discuss with your co-authors how the paper will be submitted to PubMed Central, and who will do so (all authors can submit and approve).

As of today, there have been 2.6 million articles that have been deposited into PubMed Central.  This allows anyone to access and read these freely without having to subscribe to that paricular journal!

Please contact me with any questions and/or concerns that you may have.